{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:04:39Z","timestamp":1790417079003,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Suzhou Science and Technology Project","award":["SYSD2016153"],"award-info":[{"award-number":["SYSD2016153"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12944-018-0846-x","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T13:45:00Z","timestamp":1535550300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Fibroblast growth factor 21 inhibits atherosclerosis in apoE\u2212\/\u2212 mice by ameliorating Fas-mediated apoptosis"],"prefix":"10.1186","volume":"17","author":[{"given":"Xinxin","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongshan","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guidong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"846_CR1","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, Sandusky GE, Hammond LJ, Moyers JS, Owens RA, Gromada J, Brozinick JT, Hawkins ED, Wroblewski VJ, Li DS, Mehrbod F, Jaskunas SR, Shanafelt AB. FGF-21 as a novel metabolic regulator. J Clin Invest. 2005;115:1627\u201335.","journal-title":"J Clin Invest"},{"issue":"13","key":"846_CR2","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.1074\/jbc.M116.762922","volume":"292","author":"KM Alonge","year":"2017","unstructured":"Alonge KM, Meares GP, Hillgartner FB. Glucagon and Insulin Cooperatively Stimulate Fibroblast Growth Factor 21 Gene Transcription by Increasing the Expression of Activating Transcription Factor 4. J Biol Chem. 2017;292(13):5239\u201352.","journal-title":"J Biol Chem"},{"issue":"11","key":"846_CR3","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1194\/jlr.M044784","volume":"55","author":"MK Brahma","year":"2014","unstructured":"Brahma MK, Adam RC, Pollak NM, Jaeger D, Zierler KA, P\u00f6cher N, Schreiber R, Romauch M, Moustafa T, Eder S, Ruelicke T, Preiss-Landl K, Lass A, Zechner R, Haemmerle G. Fibroblast growth factor 21 is induced upon cardiac stress and alters cardiac lipid homeostasis. J Lipid Res. 2014;55(11):2229\u201341.","journal-title":"J Lipid Res"},{"issue":"4","key":"846_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/med.21390","volume":"36","author":"WY So","year":"2016","unstructured":"So WY, Leung PS. Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus. Med Res Rev. 2016;36(4):672\u2013704.","journal-title":"Med Res Rev"},{"issue":"11","key":"846_CR5","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1210\/en.2009-0532","volume":"150","author":"MK Badman","year":"2009","unstructured":"Badman MK, Koester A, Flier JS, Kharitonenkov A, Maratos-Flier E. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology. 2009;150(11):4931\u201340.","journal-title":"Endocrinology"},{"issue":"4","key":"846_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cmet.2017.03.005","volume":"25","author":"LD BonDurant","year":"2017","unstructured":"BonDurant LD, Ameka M, Naber MC, Markan KR, Idiga SO, Acevedo MR, Walsh SA, Ornitz DM, Matthew J. Potthoff.FGF21 Regulates Metabolism ThroughAdipose-Dependent and -Independent Mechanisms. Cell Metab. 2017;25(4):935\u2013944.e4.","journal-title":"Cell Metab"},{"issue":"26","key":"846_CR7","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.1073\/pnas.0904187106","volume":"106","author":"MJ Potthoff","year":"2009","unstructured":"Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R, Mohammadi M, Finck BN, Mangelsdorf DJ, Kliewer SA, Burgess SC. FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc Natl Acad Sci U S A. 2009;106(26):10853\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"846_CR8","doi-asserted-by":"publisher","first-page":"10490","DOI":"10.1074\/jbc.M112.429852","volume":"288","author":"L Yu","year":"2013","unstructured":"Yu L, Wong K, Walsh K, Gao B, Zang M. Retinoic Acid Receptor \u03b2 Stimulates Hepatic Induction of Fibroblast Growth Factor 21 to Promote Fatty Acid Oxidation and Control Whole-body Energy Homeostasis in Mice. J Biol Chem. 2013;288(15):10490\u2013504.","journal-title":"J Biol Chem"},{"issue":"4","key":"846_CR9","doi-asserted-by":"publisher","first-page":"858","DOI":"10.2337\/db16-1212","volume":"66","author":"D Wanders","year":"2017","unstructured":"Wanders D, Forney LA, Stone KP, Burk DH, Pierse A, Gettys TW. FGF21 Mediates the Thermogenic and Insulin-Sensitizing Effects of Dietary Methionine Restriction but Not Its Effects on Hepatic Lipid Metabolism. Diabetes. 2017;66(4):858\u201367.","journal-title":"Diabetes"},{"issue":"3","key":"846_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.molmet.2013.05.005","volume":"2","author":"AC Adams","year":"2013","unstructured":"Adams AC, Coskun T, Cheng CC, Farrell LSO, Dubois SL, Kharitonenkov A. Fibroblast growth factor 21 is not required for the antidiabetic actions of the thiazoladinediones. Mol Metab. 2013;2(3):205\u201314.","journal-title":"Mol Metab"},{"issue":"12","key":"846_CR11","doi-asserted-by":"publisher","first-page":"e15534","DOI":"10.1371\/journal.pone.0015534","volume":"5","author":"Z Lin","year":"2010","unstructured":"Lin Z, Wu Z, Yin X, Liu Y, Yan X, Lin S, Xiao J, Wang X, Feng W, Li X. Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile. PLoS One. 2010;5(12):e15534.","journal-title":"PLoS One"},{"issue":"1","key":"846_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bbrc.2015.02.081","volume":"459","author":"Y Joki","year":"2015","unstructured":"Joki Y, Ohashi K, Yuasa D, Shibata R, Ito M, Matsuo K, Kambara T, Uemura Y, Hayakawa S, Hiramatsu-Ito M, Kanemura N, Ogawa H, Daida H, Murohara T, Ouchi N. FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism. Biochem Biophys Res Commun. 2015;459(1):124\u201330.","journal-title":"Biochem Biophys Res Commun"},{"key":"846_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12933-015-0229-9","volume":"14","author":"X Yang","year":"2015","unstructured":"Yang X, Liu L, Xu A, Zhou P, Long Z, Yiting T, Chen X, Tang W, Huang G, Zhou Z. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2015;14:72.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"846_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","volume":"23","author":"S Talukdar","year":"2016","unstructured":"Talukdar S, Zhou Y, Li D, Rossulek M, Dong J, Somayaji V, Weng Y, Clark R, Lanba A, Owen B, Brenner M, Trimmer JK, Gropp KE, Chabot JR, Erion DM, Rolph T, Goodwin B, Calle R. A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human Primates and type 2 diabetic subjects. Cell Metab. 2016;23(3):427\u201340.","journal-title":"Cell Metab"},{"issue":"6","key":"846_CR15","doi-asserted-by":"publisher","first-page":"e005344","DOI":"10.1161\/JAHA.116.005344","volume":"6","author":"CH Lee","year":"2017","unstructured":"Lee CH, Woo YC, Chow WS, Cheung CYY, Fong CHY, Yuen MMA, Xu A, Tse HF, Lam KSL. Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus. J Am Heart Assoc. 2017;6(6):e005344.","journal-title":"J Am Heart Assoc"},{"issue":"14","key":"846_CR16","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1161\/01.CIR.0000160864.31351.C1","volume":"111","author":"J Zhou","year":"2005","unstructured":"Zhou J, Lhotak S, Hilditch BA, Austin RC. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation. 2005;111(14):1814\u201321.","journal-title":"Circulation"},{"issue":"2","key":"846_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4161\/cc.9.2.10596","volume":"9","author":"L Ozcan","year":"2010","unstructured":"Ozcan L, Tabas I. Pivotal role of calcium\/calmodulin-dependent protein kinase II in ER stress-induced apoptosis. Cell Cycle. 2010;9(2):223\u20134.","journal-title":"Cell Cycle"},{"issue":"5","key":"846_CR18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00380-014-0557-9","volume":"30","author":"X Wu","year":"2015","unstructured":"Wu X, Qi YF, Chang JR, Lu WW, Zhang JS, Wang SP, Cheng SJ, Zhang M, Fan Q, Lv Y, Zhu H, Xin MK, Lv Y, Liu JH. Possible role of fibroblast growth factor 21 on atherosclerosisvia amelioration of endoplasmic reticulum stress-mediated apoptosis in apoE(-\/-) mice. Heart Vessel. 2015;30(5):657\u201368.","journal-title":"Heart Vessel"},{"issue":"3","key":"846_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1101\/gad.177857.111","volume":"26","author":"FM Fisher","year":"2012","unstructured":"Fisher FM, Kleiner S, Douris N, Fox EC, Mepani RJ, Verdeguer F, Wu J, Kharitonenkov A, Flier JS, Maratos-Flier E, Spiegelman BM. FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012;26(3):271\u201381.","journal-title":"Genes Dev"},{"issue":"6","key":"846_CR20","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/hep.27719","volume":"61","author":"P Lu","year":"2015","unstructured":"Lu P, Yan J, Liu K, Garbacz WG, Wang P, Xu M, Ma X, Xie W. Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21. Hepatology. 2015;61(6):1908\u201319.","journal-title":"Hepatology"},{"issue":"11","key":"846_CR21","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.2337\/db13-0645","volume":"62","author":"WY So","year":"2013","unstructured":"So WY, Cheng Q, Chen L, Evans-Molina C, Xu A, Lam KSL, Leung PS. High Glucose Represses \u03b2-Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets: Involvement of Peroxisome Proliferator\u2013Activated Receptor \u03b3 Signaling. Diabetes. 2013;62(11):3751\u20139.","journal-title":"Diabetes"},{"issue":"6","key":"846_CR22","doi-asserted-by":"publisher","first-page":"H1029","DOI":"10.1152\/ajpheart.00527.2015","volume":"309","author":"EM Domouzoglou","year":"2015","unstructured":"Domouzoglou EM, Naka KK, Vlahos AP, Papafaklis MI, Michalis LK, Tsatsoulis A, Maratos-Flier E. Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21. Am J Physiol Heart Circ Physiol. 2015;309(6):H1029\u201338.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"846_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12872-015-0077-2","volume":"15","author":"E Li","year":"2015","unstructured":"Li E, Wang T, Wang F, Wang T, Sun LQ, Li L, Niu SH, Zhang JY. FGF21 protects against ox-LDL induced apoptosis through suppressing CHOP expression in THP1 macrophage derived foam cells. BMC Cardiovasc Disord. 2015;15:80.","journal-title":"BMC Cardiovasc Disord"},{"issue":"23","key":"846_CR24","first-page":"3417","volume":"123","author":"Y L\u00fc","year":"2010","unstructured":"L\u00fc Y, Liu JH, Zhang LK, DU J, Zeng XJ, Hao G, Huang J, Zhao DH, Wang GZ, Zhang YC. Fibroblast growth factor 21 as a possible endogenous factor inhibits apoptosis in cardiacendothelial cells. Chin Med J. 2010;123(23):3417\u201321.","journal-title":"Chin Med J"},{"issue":"21","key":"846_CR25","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1161\/CIRCULATIONAHA.115.015308","volume":"131","author":"Z Lin","year":"2015","unstructured":"Lin Z, Pan X, Wu F, Ye D, Zhang Y, Wang Y, Jin L, Lian Q, Huang Y, Ding H, Triggle C, Wang K, Li X, Xu A. Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice. Circulation. 2015;131(21):1861\u201371.","journal-title":"Circulation"},{"issue":"2","key":"846_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1017\/S0007114510003478","volume":"105","author":"I K\u00e4mmerer","year":"2011","unstructured":"K\u00e4mmerer I, Ringseis R, Eder K. Feeding a thermally oxidised fat inhibits atherosclerotic plaque formation in the aortic root of LDLreceptor-deficient mice. Br J Nutr. 2011;105(2):190\u20139.","journal-title":"Br J Nutr"},{"key":"846_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","volume":"18","author":"G Gaich","year":"2013","unstructured":"Gaich G, Chien JY, Fu H, Glass LC, Deeg MA, Holland WL, Kharitonenkov A, Bumol T, Schilske HK, Moller DE. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 2013;18:333\u201340.","journal-title":"Cell Metab"},{"issue":"Suppl 2","key":"846_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0300-8932(10)70150-0","volume":"63","author":"JJ Badim\u00f3n","year":"2010","unstructured":"Badim\u00f3n JJ, Santos-Gallego CG, Badim\u00f3n L. Importance of HDL cholesterol in atherothrombosis: how did we get here? Where are we going? Rev Esp Cardiol. 2010;63(Suppl 2):20\u201335.","journal-title":"Rev Esp Cardiol"},{"issue":"4","key":"846_CR29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.ecl.2014.08.001","volume":"43","author":"CG Santos-Gallego","year":"2014","unstructured":"Santos-Gallego CG, Badimon JJ, Rosenson RS. Beginning to understand high-density lipoproteins. Endocrinol Metab Clin N Am. 2014;43(4):913\u201347.","journal-title":"Endocrinol Metab Clin N Am"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0846-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-018-0846-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-018-0846-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T19:17:41Z","timestamp":1567019861000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-018-0846-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["846"],"URL":"https:\/\/doi.org\/10.1186\/s12944-018-0846-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"16 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We declare that 1) the manuscript, or part of it, neither has been published nor is currently under consideration for publication by any other journal. 2) We agree to submit our manuscript to Lipids in Health and Disease.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"203"}}